Clinical Trials Browser

Phase 3 × Uterine Cervical Neoplasms × Irinotecan × Clear all

NCT06459180 2026-05-27

TroFuse-020

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT04697628 2026-02-24

innovaTV 301

Phase 3 Completed

502 enrolled 18 charts 1 FDA

Uterine Cervical Neoplasms

NCT04943627 2022-10-05

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Phase 3 Withdrawn

Uterine Cervical Neoplasms